BioVie (BIVI) vs Tempest Therapeutics (TPST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BioVie (BIVI) has outperformed Tempest Therapeutics (TPST) over the past year, losing 30.3% versus a loss of 92.6%. Over five years, TPST leads with a -99.6% price change compared with -99.8% for BIVI. Tempest Therapeutics is the larger company by market cap ($13.4 million vs $12.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIVI | TPST |
|---|---|---|
| Share price | $1.40 | $0.7914 |
| Market cap | $12.16M | $13.37M |
| 1-day change | -2.78% | +0.50% |
| YTD return | +20.69% | -72.43% |
| 1-year return | -30.35% | -92.63% |
| 5-year return | -99.76% | -99.59% |
| EPS (TTM) | $-3.05 | $-3.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.79 | $12.23 |
| 52-week low | $0.82 | $0.743 |
| Distance from 52-week high | -63.06% | -93.53% |
| Average volume | 4.60M | 2.59M |
| Shares outstanding | 8.68M | 16.89M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BIVI has outperformed TPST by 62.3 percentage points over the past year.
BIVI vs TPST FAQ
Which is bigger, BioVie or Tempest Therapeutics?
Tempest Therapeutics (TPST) is larger, with a market capitalization of $13.37M compared with $12.16M for BioVie (BIVI).
Which stock has performed better over the past year, BIVI or TPST?
BIVI returned -30.35% over the past 12 months, compared with -92.63% for TPST (price return, excluding dividends). Past performance does not predict future results.
Are BioVie and Tempest Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.